Steven D Chernausek1, Silva Arslanian2, Sonia Caprio3, Kenneth C Copeland1, Laure El ghormli4, Megan M Kelsey5, Michaela B Koontz6, Carisse M Orsi7, Denise Wilfley8. 1. Department of Pediatrics, University of Oklahoma Health Sciences Center, Oklahoma City, OK. 2. Children's Hospital of Pittsburgh of University of Pittsburgh Medical Center, Pittsburgh, PA. 3. Department of Pediatrics, Yale University School of Medicine, New Haven, CT. 4. The George Washington University Biostatistics Center, Rockville, MD elghorml@bsc.gwu.edu. 5. Department of Endocrinology, University of Colorado School of Medicine, Aurora, CO. 6. Department of Pediatrics, School of Medicine, Case Western Reserve University, Cleveland, OH. 7. University of Texas Health Science Center at San Antonio, San Antonio, TX. 8. Department of Psychiatry, Washington University School of Medicine, St. Louis, MO.
Abstract
OBJECTIVE: Children whose parents have diabetes are at increased risk for developing type 2 diabetes. This report assessed relationships between parental diabetes status and baseline demographics, anthropometrics, metabolic measurements, insulin sensitivity, and β-cell function in children recently diagnosed with type 2 diabetes. RESEARCH DESIGN AND METHODS: The sample included 632 youth (aged 10-17 years) diagnosed with type 2 diabetes for <2 years who participated in the TODAY clinical trial. Medical history data were collected at baseline by self-report from parents and family members. Youth baseline measurements included an oral glucose tolerance test and other measures collected by trained study staff. RESULTS:Youth exposed to maternal diabetes during pregnancy (whether the mother was diagnosed with diabetes prior to pregnancy or had gestational diabetes mellitus) were diagnosed at younger ages (by 0.6 years on average), had greater dysglycemia at baseline (HbA1c increased by 0.3% [3.4 mmol/mol]), and had reduced β-cell function compared with those not exposed (C-peptide index 0.063 vs. 0.092). The effect of maternal diabetes on β-cell function was observed in non-Hispanic blacks and Hispanics but not whites. Relationships with paternal diabetes status were minimal. CONCLUSIONS:Maternal diabetes prior to or during pregnancy was associated with poorer glycemic control and β-cell function overall but particularly in non-Hispanic black and Hispanic youth, supporting the hypothesis that fetal exposure to aberrant metabolism may have long-term effects. More targeted research is needed to understand whether the impact of maternal diabetes is modified by racial/ethnic factors or whether the pathway to youth-onset type 2 diabetes differs by race/ethnicity.
RCT Entities:
OBJECTIVE:Children whose parents have diabetes are at increased risk for developing type 2 diabetes. This report assessed relationships between parental diabetes status and baseline demographics, anthropometrics, metabolic measurements, insulin sensitivity, and β-cell function in children recently diagnosed with type 2 diabetes. RESEARCH DESIGN AND METHODS: The sample included 632 youth (aged 10-17 years) diagnosed with type 2 diabetes for <2 years who participated in the TODAY clinical trial. Medical history data were collected at baseline by self-report from parents and family members. Youth baseline measurements included an oral glucose tolerance test and other measures collected by trained study staff. RESULTS: Youth exposed to maternal diabetes during pregnancy (whether the mother was diagnosed with diabetes prior to pregnancy or had gestational diabetes mellitus) were diagnosed at younger ages (by 0.6 years on average), had greater dysglycemia at baseline (HbA1c increased by 0.3% [3.4 mmol/mol]), and had reduced β-cell function compared with those not exposed (C-peptide index 0.063 vs. 0.092). The effect of maternal diabetes on β-cell function was observed in non-Hispanic blacks and Hispanics but not whites. Relationships with paternal diabetes status were minimal. CONCLUSIONS:Maternal diabetes prior to or during pregnancy was associated with poorer glycemic control and β-cell function overall but particularly in non-Hispanic black and Hispanic youth, supporting the hypothesis that fetal exposure to aberrant metabolism may have long-term effects. More targeted research is needed to understand whether the impact of maternal diabetes is modified by racial/ethnic factors or whether the pathway to youth-onset type 2 diabetes differs by race/ethnicity.
Authors: Paul W Franks; Helen C Looker; Sayuko Kobes; Leslie Touger; P Antonio Tataranni; Robert L Hanson; William C Knowler Journal: Diabetes Date: 2006-02 Impact factor: 9.461
Authors: Ruth S Weinstock; Paula M Trief; Laure El Ghormli; Robin Goland; Siripoom McKay; Kerry Milaszewski; Jeff Preske; Steven Willi; Patrice M Yasuda Journal: Diabetes Care Date: 2015-03-17 Impact factor: 19.112
Authors: D Dabelea; R L Hanson; R S Lindsay; D J Pettitt; G Imperatore; M M Gabir; J Roumain; P H Bennett; W C Knowler Journal: Diabetes Date: 2000-12 Impact factor: 9.461
Authors: R Singh; E Pearson; P J Avery; M I McCarthy; J C Levy; G A Hitman; M Sampson; M Walker; A T Hattersley Journal: Diabetologia Date: 2006-05-16 Impact factor: 10.122
Authors: Tine D Clausen; Elisabeth R Mathiesen; Torben Hansen; Oluf Pedersen; Dorte M Jensen; Jeannet Lauenborg; Peter Damm Journal: Diabetes Care Date: 2007-11-13 Impact factor: 19.112
Authors: David J Pettitt; Jean M Lawrence; Jennifer Beyer; Teresa A Hillier; Angela D Liese; Beth Mayer-Davis; Beth Loots; Giuseppina Imperatore; Lenna Liu; Lawrence M Dolan; Barbara Linder; Dana Dabelea Journal: Diabetes Care Date: 2008-08-11 Impact factor: 17.152
Authors: Lena M Thorn; Carol Forsblom; Johan Wadén; Jenny Söderlund; Milla Rosengård-Bärlund; Markku Saraheimo; Outi Heikkilä; Kustaa Hietala; Kim Pettersson-Fernholm; Jorma Ilonen; Per-Henrik Groop Journal: Diabetes Care Date: 2008-10-03 Impact factor: 19.112
Authors: Dana Dabelea; Elizabeth J Mayer-Davis; Archana P Lamichhane; Ralph B D'Agostino; Angela D Liese; Kendra S Vehik; K M Venkat Narayan; Phillip Zeitler; Richard F Hamman Journal: Diabetes Care Date: 2008-03-28 Impact factor: 19.112
Authors: Amy G Huebschmann; Rachel R Huxley; Wendy M Kohrt; Philip Zeitler; Judith G Regensteiner; Jane E B Reusch Journal: Diabetologia Date: 2019-08-27 Impact factor: 10.122
Authors: Adeniyi Francis Fagbamigbe; Emma Norrman; Christina Bergh; Ulla-Britt Wennerholm; Max Petzold Journal: PLoS One Date: 2021-06-25 Impact factor: 3.240
Authors: Jeffrey S Barrett; Christina Bucci-Rechtweg; S Y Amy Cheung; Margaret Gamalo-Siebers; Sebastian Haertter; Janina Karres; Jan Marquard; Yeruk Mulugeta; Cecile Ollivier; Ashley Strougo; Lisa Yanoff; Lynne Yao; Philip Zeitler Journal: Clin Pharmacol Ther Date: 2020-03-16 Impact factor: 6.875
Authors: Silva Arslanian; Fida Bacha; Margaret Grey; Marsha D Marcus; Neil H White; Philip Zeitler Journal: Diabetes Care Date: 2018-12 Impact factor: 19.112